Moreover, Maki-Nevala and colleagues found higher methylation levels in four CIMP marker genes, namely NEUROG1, CDKN2A, IGF2, and CRABP1, in MMR-proficient adenomas compared to normal mucosa [45,46]. This evidence concerns the gene CRABP1 and adenoma.